TMC207
CR011929
Phase 2 small_molecule completed
Quick answer
TMC207 for Tuberculosis is a Phase 2 program (small_molecule) at Janssen Cilag International NV with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen Cilag International NV
- Indication
- Tuberculosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed